Scoggin Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55M Buy
2,150,000
+150,000
+8% +$3.53M 5.89% 4
2026
Q1
$29.9M Buy
2,000,000
+825,000
+70% +$14.1M 2.88% 8
2025
Q4
$17.1M Buy
1,175,000
+425,000
+57% +$7.41M 2.62% 11
2025
Q3
$13.5M Sell
750,000
-500,000
-40% -$7.33M 2.11% 12
2025
Q2
$21.3M Buy
1,250,000
+75,000
+6% +$751K 4.44% 7
2025
Q1
$8.51M Buy
1,175,000
+600,000
+104% +$6.83M 2.37% 19
2024
Q4
$8.08M Sell
575,000
-175,000
-23% -$2.59M 1.64% 17
2024
Q3
$8.89M Buy
750,000
+250,000
+50% +$2.59M 2.12% 11
2024
Q2
$4.65M Buy
+500,000
New +$2.55M 1.55% 16

Other funds holding CORZ

Scoggin Management's CORZ Position: Q2 2026 in Review

Scoggin Management increased its Core Scientific (CORZ) stake by 7.5% in Q2 2026, buying an estimated $3.53M and bringing the position to 2,150,000 shares worth $55M. The position accounts for 5.89% of the portfolio, ranked #4.

Scoggin Management first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Scoggin Management held 2,150,000 shares of Core Scientific worth $55M as of Q2 2026.
  • Scoggin Management bought 150,000 Core Scientific shares in Q2 2026, an estimated $3.53M.
  • Core Scientific made up 5.89% of Scoggin Management's portfolio in Q2 2026, its #4 holding.
  • Scoggin Management first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Scoggin Management's 13F filing for Q2 2026, filed 14 Aug 2026.